Nemko certifies PCIB laser system
Nemko, a Norway-based notified body, has certified and granted CE mark to PCI Biotech's (PCIB) PCI 652nm laser.
PCIB said its PCI 652nm laser will be used in the Phase II study of Amphinex in head and neck cancer patients.
PCIB develops light directed drug delivery system based on the company's patented photochemical internalisation (PCI) technology.
Based on the company's PCI technology, the company follows a dual strategy to improve the effect both of existing drugs and gene therapy treatments.
Latest News
Related News
Related Sectors
Specialty Devices> Drug Delivery Devices
Related Dates
2012> January
Related Industries
Pharmaceuticals and Healthcare> Medical Devices> Drug Delivery Devices> Niche technologies> Gene delivery
Specialty Devices> Drug Delivery Devices
Related Dates
2012> January
Related Industries
Pharmaceuticals and Healthcare> Medical Devices> Drug Delivery Devices> Niche technologies> Gene delivery
Related Insight
Suppliers Directory
Specialty Devices
Anesthesia & Respiratory Devices
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Drug Delivery Devices
Orthopedic Devices
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Drug Delivery Devices Intelligence
Merger Between Phillips and Medisize
Published by Phillips-Medisize
Specialty Devices > Drug Delivery Devices > White Papers
Medisize Brochure
Published by Phillips-Medisize
Specialty Devices > Drug Delivery Devices > White Papers
Buy the latest industry research online today!
External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500

Comments may be moderated for spam, obscenities or defamation.